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ABSTRACT: Herein we have engineered a smart nuclear targeting thiol-modified riboflavin-gold nano assembly, RfS@AuNPs, 
which accumulates selectively in nucleus without any nuclear-targeting peptides (NLS/RGD) and shows photophysically in vitro 
DNA intercalation. A theoretical model using Molecular Dynamics has been developed to probe the mechanism of formation and 
stability as well as dynamics of the RfS@AuNPs in aqueous solution and within DNA microenvironment. The RfS@AuNPs  
facilitate the binucleated cell formation that is reflected in the significant increase of DNA damage marker, γ-H2AX as well as the 
arrest of most of the HeLa cells at pre-G1 phase indicating cell death. Moreover, a significant upregulation of apoptotic markers 
confirms that the cell death occurs through apoptotic pathway. Analyses of the microarray gene expression of RfS@AuNPs treated 
HeLa cells show significant alterations in vital biological processes necessary for cell survival. Taken together, our study reports a 
unique nuclear targeting mechanism through targeting the riboflavin receptors, which are upregulated in cancer cells and induce 
apoptosis in the targeted cells. 
Introduction  
The therapeutic applications of  nanoparticles in regulating the 
live cell functions have become the most challenging aspects 
of nano-biotechnology
1,2
 and nanomedicine
3,4
. The gold 
nanoparticles (AuNPs) have received considerable attention in 
the biological and biomedical communities due to their 
potential use in diagnostic and therapeutic applications
3,5-8
. 
The AuNPs are usually conjugated with drugs to enhance the 
efficiency of targeted delivery, thus hold great promises in 
tumour therapy and drug delivery due to their ability to serve 
as biocompatible scaffolds for intracellular targeting
9,10
.
 
Moreover, their nanoscale size allows them to enter cells and 
to target the different organelles i.e. endosome, nucleus and 
mitochondria
11-13
. The riboflavin (Rf) is widely distributed in 
human tissues in free or conjugated forms and plays an 
important role in formation of flavoprotein enzyme
14,15
. The 
Rf that consists of an isoalloxazin moiety and a ribityl chain, 
possesses mixed features of hydrophobic and hydrophilic 
functionalities
16,17
, which generate its affinity towards different 
biological macromolecules including proteins and DNA
18
. 
Moreover, the Rf receptor protein constitutes one type of 
tumour biomarkers due to their over expression in malignant 
cells of human breast and prostate cancers
19,20
.    
 
 Scheme 1: Synthetic route of RfS@AuNPs
 
Taking advantage of the above properties of Rf and AuNPs, 
we have attempted to design and synthesize one of their 
modified conjugates, RfS@AuNPs which could facilitate 
significant photophysical changes due to DNA intercalation in 
vitro. Their smart nuclear targeted accumulation in HeLa cells 
can perturb the highly regulated cell cycles leading to 
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Figure 1 (A) TEM micrograph of RfS@AuNPs. (B) Absorption spectra of RfSH (5 ×10
-6
M), CAuNPs (0.25nM and RfS@AuNPs 
(before and after removing free RfSH).Inset shows the change in fluorescence intensity of RfSH up on addition of CAuNPs and 
subsequent removal of free RfSH (C) IR spectra of RfSH and RfS@AuNP. Inset diagram shows the disappearance of S-H band 
after nano conjugation. 
 
DNA damage and ultimate cell death. We have also attempted 
to elucidate the pathway of cell death by global gene 
expression through microarray analysis.  
Results and Discussion 
Optical properties of RfS@AuNPs: 
The terminal hydroxyl group of ribityl chain of Rf has been 
modified due to lack of suitable functional group required for 
the covalent attachment with citrate capped AuNPs (CAuNPs) 
without affecting isoalloxazine moiety. This modification is 
carried out by dimercaptoethane through tosylation (1) 
followed by substitution (2) which converts Rf to RfSH 
(Scheme 1). Now RfSH can easily be attached on the surface 
of 20-25 nm CAuNPs by ligand exchange through Au-S bond 
resulting in the formation of RfS@AuNPs  (Scheme 1, Figure 
1A, S1).  
The absorption spectra of Rf and RfSH show two maxima at 
368 nm and 444 nm (Figure S2A) which remain more or less 
unaffected with increasing [CAuNPs] (0.25-1.5 nM) in 5 µM 
aqueous solution of RfSH (Figure 1B, S2B); hence, no 
significant interaction between isoaloxazine moiety and 
CAuNPs (TEM Figure S4B) might be inferred. Free RfSH is 
removed from the complex by centrifugation followed by 
washing and the resuspended solution is used for further 
experiments after sonication (Figure 1B) .The red shift of the 
CAuNPs Plasmon peak by ~4 nm at higher concentration of 
nanoparticles is observed probably due to change in the 
dielectric environment via surface attachment of RfSH (Figure 
S2B). It has been estimated from the absorption spectra that ∼ 
22800 RfSH molecules are attached with each AuNP which is 
much higher than that for Rf [∼ 4680] (S4/Figure S3).  It is 
now evident that RfSH has ∼ 5 times greater binding affinity 
towards CAuNP compared to Rf (section S4). Again the 
fluorescence maximum of Rf (λmax = 524 nm) is very close to 
the absorption maximum of CAuNP (λmax = 525 nm). 
Therefore energy transfer may be responsible for quenching of 
fluorescence of Rf with gradual increase of [CAuNPs] 
(section S6, Figure S5). The fluorescence lifetimes (τ) of Rf 
and RfSH in aqueous medium are 4.73 ns and 4.69 ns 
respectively (Figure S6) which remain more or less unchanged 
with the addition of higher [CAuNPs] (1 nM). This suggests 
that the fluorescence quenching of Rf or RfSH is a static one 
due to the formation of ground state complex with AuNPs.  
The attachment of Rf and RfSH on AuNPs surface has been 
verified further by FT-IR (Figure 1C) where the peak of RfSH 
at 2552 cm
-1 
disappears after the formation of RfS@AuNP. 
The above results indicate that the complex formed between 
RfSH and AuNP in ground state is quite stable and might be 
able to interact with the biological macro-molecules like 
DNA.  
  
In vitro DNA intercalation by RfS@AuNPs 
The isoalloxazine moiety of Rf is able to intercalate DNA due 
to planer structure
21,22
. Therefore we have studied binding 
interaction of RfS@AuNPs with calf thymus DNA (ct-DNA) 
as a model system. With increasing [RfS@AuNPs] the 
absorption maximum of ct-DNA at 257 nm is blue shifted by 
∼ 15 nm which is higher w.r.t. Rf (∼ 4 nm) as well as 
Rf@AuNPs (∼ 8 nm) (Figure 2A, S7). Upon excitation (λex = 
444 nm) a regular increase of fluorescence intensity with the 
gradual addition of ct-DNA (10-50 µM) is observed for a fixed 
[RfS@AuNPs] (Figure S8). This fluorescence enhancement 
occurs due to stacking interaction of isoalloxazine moiety with 
the base pairs of DNA, which forces them to enter inside the 
more constrained environment that reduces nonradiative 
decay. The binding constant of RfS@AuNPs with DNA (Ka = 
1.1 × 10
4
 M
-1
) is ~ 4 times greater than that with bare RfSH 
(Ka = 2.8 × 10
3
 M
-1
). This further supports better intercalation 
of RfSH inside DNA as a nano-conjugate (Figure S8C). 
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Figure 2 (A) Absorption spectra of 10 µM DNA titrated with increasing concentration of RfS@AuNPs in tris-buffer (pH 7.2, 10mM). (B) 
CD spectra of ct-DNA titrated with increasing [RfS@AuNPs] (0.1-0.7 nM) in tris-buffer (C) Time-resolved transient absorption spectra of 
RfS@AuNPs (1 nM) (black) in presence of increasing [ct-DNA] in tris-buffer. (Inset: comparative decay profiles of RfS@AuNPs (1 nM) 
without and with ct-DNA (40µM) with decrease in average lifetime Ƭ from 2.8→2.1 µs at 360 nm and from 2.9→2 µs at 530 nm; (λex = 
355 nm). 
 
The CD spectra of ct-DNA show its conformational changes 
upon addition of Rf, RfSH, Rf@AuNPs and RfS@AuNPs 
with significant alterations in the positive CD bands in tris-
buffer (pH = 7.2). The intensities of the characteristic bands of 
ct-DNA at 245 nm and 277 nm show changes with the 
appearance of a new positive CD band around 340 nm (Figure 
2B). The intensity of negative CD band increases gradually as 
a consequence of excess of Rf, Rf-SH, Rf@AuNPs and 
RfS@AuNPs (Figure S9) in the solution suggesting the 
probability of occurrence of unwinding of the DNA helix
23
.  
Moreover, the new band around 340 nm might be induced 
from RfS@AuNPs bound to DNA helix. Recently, it has been 
reported that a similar positive CD band is observed beyond 
310 nm for dinuclear complexes due to selective binding of 
RfS@AuNPs to guanine residues of ct-DNA
24
. Therefore, it is 
worthy to mention here that these Rf, RfSH, Rf@AuNPs and 
RfS@AuNPs bind ct-DNA in the ground state. However, it is 
observed that RfS@AuNPs are much more potent intercalator 
among the others. 
 The laser flash photolysis experiments have also been 
performed to study the excited state interaction between ct-
DNA and RfS@AuNP. The triplet-triplet transient absorption 
spectrum of RfS@AuNPs shows peaks around 360 nm and 
530 nm in tris-buffer (pH = 7.2) (Supplementary section S11; 
Figure 2C). It is observed that with [ct-DNA] (10, 30, 40 µM) 
the overall triplet absorbance of RfS@AuNP drops off along 
with a comparable decrease in the lifetime (Ƭ) of the transients 
at 360 nm and 530 nm from 2.8→2.1 µs and 2.9→2 µs 
respectively. The reduction of absorbance and  lifetime of the 
transients may be due to (1) the inaccessibility of the 
chromophore i.e., isoalloxazine which is stacked within DNA 
micro- environment
25 
and (2) the formation of  ground state 
complex between RfS@AuNPs and DNA which perturbs the 
overall inter system cross over processes. Hence triplet yield 
of RfS@AuNPs decreases. The transient state data also reflect 
the ground state interaction via incorporation of RfS@AuNPs 
within DNA microenvironment. 
We have also performed stability assays of RfS@AuNPs at 
different pH (5.0, 7.2 and 8.5) employing fluorescence 
spectroscopy (Figure S12) which indicates that the 
nanoconjugate is quite stable at pH 5.0, 7.2 and 8.5 after 18 
hrs  which may also be  true for RfS@AuNPs in lysosomal 
environment
26
 where pH is around 5.0. 
 
Simulation of DNA- RfS@AuNP intercalation 
 To probe the stability as well as dynamics of the 
RfS@AuNPs in aqueous solution and within DNA 
microenvironment, we have built theoretical model using 
Molecular Dynamics (MD). The structure of RfS@AuNPs has 
been modeled and shown in Figure 3A. A small gold cluster 
such as Au144 cluster is selected as model of AuNPs which can 
bind to a maximum of 60 RfSH. A larger particle of about 20 
nm diameter is able to accommodate extremely large number 
of RfSH on it. Dynamics of RfSH on the gold nano surface 
has been probed and is shown in the video S1. The ring 
structures of RfSH form stacking interactions with each other 
to get stabilized on the AuNP surface in presence of water. Rf 
is known to intercalate DNA followed by DNA strand break 
via generation of superoxide
27
. Therefore, in conjugation to 
AuNP, when Rf comes in contact with DNA, the planer ring 
of Rf intercalates within the bases of DNA. Thus, a single 
molecule of RfS@AuNP via intercalation through its multiple 
head groups can wrap multiple strands of DNA around it. 
Here, Figure 3B shows the docked structure of RfSH into the 
DNA. MD simulation on this complex reveals that the 
stacking is energetically stable over time and provides a strong 
binding force (Video S2). If the tail of RfSH is immobilized 
on a surface like that of AuNP, it can immobilize DNA on that 
surface. An atomic model of that complex has been developed 
and the geometry is optimized. Figure 3C shows the molecular 
model of Au144(RfS)16 recruiting two strands of DNA via 
intercalation. The RfS@AuNP bound to two strands of DNA 
was subjected to MD simulation for 12 ns in aqueous media 
and found to be energetically stable for the whole duration as 
shown in video S3.  
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Figure 3 (A) Molecular model of Au144(RfS)16 or model RfS@AuNPs (B) docked structure of RfSH into the DNA.  (C) Molecular 
model of Au144(RfS)16 recruiting two strands of DNA via intercalation.
Effect of RfS@AuNPs on live cells 
We hypothesized that CAuNP functionalized with RfSH, may 
influence their distribution pattern in HeLa cells through the 
interactions of Rf with appropriate receptors inside the 
cells
28,29
. Further Rf was shown previously to induce 
apoptosis
30,31
. The  average size of RfS@AuNPs (20nm 
Figure 1A) is lesser than  the nuclear pore size (>90nm)
32,33
. 
Moreover these molecules are quite stable in physiological 
condition as shown from MD-simulation, hence can easily 
penetrate into the nuclei of the cells. To prove the above 
hypothesis, HeLa cells have been treated with Rf, RfSH, 
Rf@AuNPs and RfS@AuNPs and their cellular uptakes have 
been monitored by their auto fluorescence (λem = 525nm) in a 
time course dependent manner (Figure 4A-H). After 18 H, the 
relative fluorescence intensity analyses show the trend for 
nuclear uptake as RfS@AuNPs > Rf@AuNPs > RfSH ≅ Rf 
(Figure 4I). The nuclear uptake of RfS@AuNPs to the cells is 
markedly improved upon AuNP conjugation [~ 20 % > Rf]. 
RfS@AuNPs predominantly illustrates nuclear localization 
between 18-24 hrs time points (Figure 4A-D). The cells 
become much more rounded off in shape 12 H onwards. Post 
18 H time point depicts cellular membrane blebbing
34,35
 and 
formation of the binucleated apoptotic bodies
36,37
 (Figures 4 
M-Q) which  are the signatures  of apoptosis by RfS@AuNPs. 
The live cell imaging provides us with a more in-depth view 
of the process (Video S4).  It is to be mentioned that the 
unconjugated RfSH, Rf and CAuNP do not show any 
significant change even after 24 H treatment (Figures 4 J, K, 
L). 
We have quantified the nuclear and cytosolic distribution of 
Rf@AuNPs and RfS@AuNPs at each time point of the 
confocal images (Figure S11). We observe a preferential 
nuclear localization of RfS@AuNPs which peaks at 24 H time 
point, unlike Rf@AuNPs. We have further checked the 
induction of specific epigenetic signature in the context of 
DNA damage response upon treatment with Rf@AuNPs and 
RfS@AuNPs. Histone H2AX is a variant of H2A histone that 
is phosphorylated  to form γ-H2AX in response to double 
strand DNA breaks
38,39
. Figures 5A-F show confocal images of 
HeLa cells in which the nuclei are stained with DAPI (blue) 
and anti-γ-H2AX antibodies are with red. For cells treated 
with 0.5 nM RfS@AuNPs, bright-red DNA damage foci 
(Supplementary section S2e, Figure 5B) are observed in the 
nuclei in comparison to untreated cells (Figures 5D-F).  
  
 
 
Figure 4: Real time confocal images of 0.5 nM RfS@AuNPs 
treated HeLa cell  captured at (A) 6 H (B) 12 H (C) 18 H (D) 24 H 
(100X objective; Scale Bar represents 20 µm) and (E) 6 H (F) 12 
H (G) 18 H (H) 24 H  for Rf@AuNPs treated HeLa cells (Scale 
Bar represents 20 µm) (I) Relative green fluorescence Intensity of 
RfSH; Rf@AuNPs; RfS@AuNPs; Rf fluorescence in the HeLa 
nucleus after 12H treatment.  (J, K, L) Real-time images of cancer 
cells (HeLa) at maximum time point (24 H) after treatment of (J) 
CAuNP (K) Only Rf (L) only RfSH (Scale Bar represents 20 
µm); Panel: M, N, O, P, Q are the  representative time-lapse 
images of a HeLa cell treated with 0.5 nM RfS@AuNPs 
undergoing membrane blebbing and  binucleated (indicated by 
arrow) cell formation. (The scale bar is 10µm.) 
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These results have been reconfirmed by immunoblotting 
experiments (Figure 5I).The DNA double strand break can be 
caused by various cellular events like replication fork 
collision, apoptosis, external damage and dysfunctional 
telomeres that may lead to phosphorylation of H2AX
40,41
. 
Further, the flow-cytometric analysis has been carried out to 
monitor the ability of RfS@AuNPs to modulate cell cycles 
(Figure 5G, S10B). The Pre-G1 peak shows a huge increase in 
presence of RfS@AuNPs (∼ 46.4 % of total cells) treated for 
24 H as compared to control untreated cells (∼ 4.6 % of total 
cells). The alteration in the percentage of cells in different 
stages of cell cycle is represented graphically (Figure 5G, 
S10). Hence most of the RfS@AuNPs treated cells are 
arrested at pre-G1 phase, indicating cell death
42,43
 more 
potently as compared to Rf. The DNA fragmentation in 
apoptotic cells are quantified by DNA ladder assay and found 
to be maximum in case of RfS@AuNP treated cells (Figure 
5H).  The suggested cause for cell death in CAuNP-treated 
cells is the generation of reactive oxygen species (ROS), 
which is known to cause irreversible DNA damage
44,45
. 
 
 
Figure 5. Immuno fluorescence staining by γ-H2AX antibody. 
Confocal image of HeLa cells treated with 0.5 nM RfS@AuNPs 
(A) blue channel (B) red channel  (C)  merged  image of (A) & 
(B). Untreated HeLa (D) blue channel (E) red channel (F) merged 
image of (E) & (F). (In 100x-objective, Scale Bar = 20µm). (G)  
Flow-cytometric analysis showed % of cells in each phase (cyan-
preG1; blue-G1; red-S; black-G2) of the cell cycle for HeLa cells 
in the presence of 0.5 nM Rf@AuNPs and RfS@AuNPs, 
suggesting cell death. (H) DNA fragmentations in apoptotic cells 
are quantified by DNA ladder assay (I) Immuno-blotting by γ-
H2AX antibody. α-H3 is used as a loading control. 
 
 
Global gene expression analysis upon RfS@AuNPs 
treatment  
Treatment of the RfS@AuNPs perturbs a large number of 
biological processes in the HeLa cells, including vital 
processes like DNA repair processes, chromatin organization, 
mitosis, cell cycle etc. It is well evident from the list of 
affected processes that the gold nano assembly leads to loss of 
cell viability for the cancer cells. This fact coupled with the 
selective targeting of the cancer cells through Rf receptors 
renders a unique specificity to the gold nano assembly, and 
represents a potential mode of modern cancer therapy. 
Specific targeting and delivery of nano particle can bypass the 
non specific cytotoxic effect of radiation and chemotherapy, 
and thus, it is currently a major area of anti cancer drug 
designing. Our current study sheds light on a unique mode of 
tumor specific nano particle conjugated drug delivery and also 
advances our current understanding of nano particle effect on 
cellular processes. Selective upregulation of pro-apoptotic 
markers like Bax
46
, IL-6
47
 and subsequent down regulation of 
anti-apoptotic markers like STAT1
48
 and BCL2L12
49
 (Figure 6 
A-H,S13 and S14) also indicate that RfS@AuNPs induce 
apoptosis. 
CONCLUSION 
Here we have tried to design and synthesize a nanocojugate, 
RfS@AuNPs, which shows four times stronger binding with 
ct-DNA compared to Rf, RfSH and Rf@AuNPs. The MD-
simulation also confirms the stability of the conjugate in 
aqueous medium. Further, we have shown that the 
accumulation of RfS@AuNPs in the nuclei of the cells may 
be due to the appropriate over expressed receptor present in 
the treated HeLa cells. Most of the cells are arrested at pre-G1 
phase, inducing DNA damage and ultimately cell death. 
RfS@AuNP has a number of advantages in terms of synthesis 
and its applications in cells. The RfS@AuNP (1) can be easily 
prepared from the low cost vitamin-B2 just by a simple two 
step process, (2) has auto green fluorescence which can be 
easily tracked by simple confocal microscope (i.e. one-photon 
excitation λex = 444 nm), (3) can be used in low concentration 
as a nucleus targeting agent without attachment of any nuclear 
localizing signal (NLS/RGD) peptide, dendrimer with AuNPs 
and (4) can deliver drug molecules in the cell nucleus by 
chemical attachment. AuNP-conjugated drug can regulate 
many cellular processes in a more efficient manner as obtained 
from analysis of the microarray gene expression of 
RfS@AuNPs treated HeLa cells. RfS@AuNPs might find 
new applications in tumour diagnosis and cancer therapy.  
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Figure 6. (A) Clustering and heat maps of expression values for differentially expressed genes. Down-regulated genes are marked in green 
and up-regulated genes are marked in red. From left to right first three samples are control untreated and latter three samples are 0.5 nM 
RfS@AuNPs treated HeLa cells. (B) Overrepresentation of differentially expressed genes from microarray in cell survival related 
processes (C) Validation of candidate upregulated and down regulated genes by qRTPCR after treating the HeLa cells with RfS@AuNPs 
for 12 H. Normalization was done with 18srRNA and reference level was considered as 1. Each bar is an average of 3individual biological 
replicates. Error bars show standard deviations. (D, E) Network of differentially regulated biological processes upon nanoparticle treatment 
in HeLa cells. Nodes represent individual biological processes, and edges represent the connection between them. Network constructed 
using BiNGO tool of Cytoscape software. The colour scale represents the level of significance of the GO process (preset cut-off: p < 0.05). 
Overrepresentation of differentially expressed genes from microarray data in following categories: F. Molecular function. G. Biological 
processes. H. Signaling pathways. 
Experimental Section 
All the chemicals and solvents required for syntheses of the thiol 
derivative of Riboflavin are of analytical grade. We have 
purchased 7,8-Dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahy 
droxypentyl]benzopteridine-2,4-dione (Riboflavin), 1,2-
Ethanedithiol, from Aldrich Chemical Co., highly polymerized 
calf thymus DNA (ct-DNA) from Sisco Research Laboratory, 
India  and tris buffer, sodium chloride and hydrochloric acid (AR) 
from Merck . The chemicals have been used without further 
purification. Triple distilled water has been used for the 
preparation of all the aqueous solutions. Solvents required for 
syntheses and spectroscopic studies have been purchased from 
SRL, India and Spectrochem, India respectively. HAuCl4, 3H2O, 
trisodiumcitrate has been procurred from Sigma. Steady-state 
absorption and fluorescence spectra of Rf have been recorded 
using JASCO V-650 absorption spectrophotometer and Spex 
Fluoromax-3 Spectro-fluorimeter respectively. Time-resolved 
emission spectra of RfS@AuNPs have been obtained using a 
picosecond pulsed diode laser based TCSPC fluorescence 
spectrometer with λex ∼370 nm and MCP-PMT as a detector. 
Respective transient intermediates have been generated with third 
Page 6 of 10
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 harmonic (355 nm) output of nanosecond flash photolysis set-up 
(Applied Photophysics) containing Nd:YAG Laser (Lab series, 
Model Lab 150, Spectra Physics)50. TEM measurements have 
been carried out using an FEI, TECNAI G2F30, S-TWIN 
microscope operating at 300 kV equipped with a GATAN Orius 
SC1000B CCD camera. Flow cytometry has been performed on a 
FACS Calibur from BD Biosciences. 
SYNTHESES 
Synthesis of RfSH. 
A 500-mL round-bottomed three-necked flask fitted with a 
stirrer and a theromometer is charged with 200 mL of pyridine 
and 18.81 g (0.05 mol) of Riboflavin (Rf) in 200 mL of DMSO. 
The solution is stirred and chilled to 0°C and then 9.53 g ( 0.05 
mol) of freshly recrystallized p-toluenesulfonyl chloride is added 
in portions over a 20-min period. The reaction mixture is allowed 
to attain room temperature and is stirred for 16 H. The mixture is 
re-cooled to 0°C and poured into 100 mL of concentrated 
hydrochloric acid in 500 mL of ice water. The aqueous layer is 
extracted with 100 mL of DCM and the combined organic layers 
are washed with two 60 ml portions of brine, dried over 
magnesium sulphate and concentrated by rotary evaporation to 
yield 10.2 g of a light yellow solid of Rf-OTs.  Rf-OTs (10.61g, 
0.02 mol) is dissolved in ether (100.0 ml) by continuous stirring 
and then 1, 2-dithiane (2 g, 0.02 mol) is added in drop wise 
manner. The reaction mixture is stirred for 24 hours in presence of 
catalytic amount of NaI (0.003g, 0.00002 moles) under room 
temperature. The dark yellow product is purified using column 
chromatography and used as RfSH 
1H NMR (300 MHz, DMSO-d6) 11.34 (s, 1H, N12-H), 7.92 
(s,1H, Ar-C1-H), 7.88 (s,1H, Ar-C4-H),  5.15 (s, N14-H), 4.59 (s, 
N8-H), 4.93, 4.90, 4.87, 4.8 (m, 1H, 1H, C18, 20-H), 4.80, 4.79 
(d, 2H, C17-H), 4.63, 4.59 (d, 2H, C21-H), 3.47, 3.45, 3.43 (t, 1H, 
C19-H), 2.675, 2.671, 2.66, 2.64 (m, 2H, C24-H), 3.63 (s, 1H, 3-
OH), 2.58 (s, 1H, S25-H). 2.57-2.50 (m, 2H, C23-H), 2.48 (s,3H, 
C15-H), 2.40 (s, 3H, C16-H). [Figure S1 A] 
13C NMR (75 MHz, DMSO-d6): 117.5(C1,C4), 135.7(C2), 
136.7 (C3)150.8(C6), 146.1(C7), 132.1 (C9), 134.0(C10), 155.6 
(C11), 160.0 (C13), 18.8 (C15,C16), 47.36 (C17), 63.4 (C18), 
68.8(C19), 72.8 (C20), 73.6(C21), 40.3(C23), 38.2 (C24). [Figure 
S1 B] 
ESI mass of RfSH: m/z obtained for RfSH is: 454.16 (Exact 
mass 454.13) [Figure S1C] 
Preparation of RfS@AuNPs: Aqueous solution of RfSH (5×10-4 
M) is mixed with 1 nM CAuNPs in 1:4 ratio. Resulting solution 
is kept for ∼ 4 H and centrifuged (at 4000 rpm) for 90 minutes. 
This process is repeated thrice. The bottom part is collected, 
redispersed in water and used as RfS@AuNPs for each 
experimental step. Concentration used for cell treatment is 0.5 nM 
.  
Methods of MD-simulation: Coordinates of an icosahedral 
metallic gold cluster comprising 144 Au atoms are obtained from 
the published work of Lopez-Acevedo et al.51. DNA intercalated 
with a thiazole orange dye is obtained from the Protein Data Bank 
(PDB ID: 108D). Structure of thiooxalated riboflavin (RfSH) is 
drawn in Schrodinger maestro molecular modeling environment. 
Multiple RfSH molecules are attached to the surface of the Au 
cluster through the Au-S linkage. The RfSH@AuNP complex is 
then subjected to the MD simulation in aqueous phase for 12 ns. 
Prior to production MD structure is minimized using a previously 
published five step relaxation protocol52. In the DNA structure, 
108D, the ligand is exchanged for RfSH using Auto Dock 4.2 52 
followed by energy minimization in Schrodinger Maestro. Two 
DNA strands intercalated with RfSH are then attached to the 
surface of Au144 via Au-S linkage. DNA bound RfS@AuNP 
complex is then solvated in single point charge water model and 
the dynamics of the system is probed for 12 ns in normal 
temperature and pressure. Restraints are added to the terminal 
base pairs to prevent base fraying. All the MD simulations are 
performed in Desmond (Academic version 2016-4) as 
implemented in Schrodinger Maestro53 (using previously 
published protocol)52. 
Microarray analysis and its validation 
Microarray analysis: Raw data are Quantile normalized and 
baseline transformation is done to median of all samples using 
Gene Spring GX 12.5 software (Agilent Technologies Inc, Santa 
Clara, USA).  
Statistical analysis and differentially expressed genes: 
Differentially expressed probe sets (Genes) upon treatment in 
comparison to untreated cells are identified by applying Volcano 
Plot using a fold-change threshold of absolute fold-change greater 
than or equal to 1.5 and a statistically significant t-test P value 
threshold adjusted for false discovery rate of less than 0.001. 
Statistically significantly enriched transcripts with a P value 
adjusted for false discovery rate of less than 0.05 derived using 
the hyper geometric distribution test corresponding to 
differentially expressed genes are determined using student t-test 
with Benjamini Hocheberg FDR test.  Unsupervised hierarchical 
clustering of differentially expressed genes upon treatment in 
comparison to untreated are done using Euclidian algorithm with 
Centroid linkage rule to identify gene clusters whose expression 
levels are significantly reproduced across the replicates. 
Biological pathways and gene ontology enrichment analysis: 
Differentially expressed gene list is subjected for biological 
significance analysis by GOElite tool (Ref).  21887 protein coding 
genes are used as the background and differentially expressed 
gene list is used as query.  Database of Gene Ontology categories, 
Wiki pathways, KEGG Pathways, Pathway Commons, Pheno 
Ontology, Diseases, Protein Domains, Transcription factor targets 
and Tissue expression are configured for significant analysis.  
Each query list is subjected to over representation analysis against 
each of the above databases.  A Z score and permutation or 
Fisher’s Exact Test p-value are calculated to assess over-
representation of enriched biological categories.  
Gene regulatory network modeling: Statistically significant 
dysregulated genes are used as input for identification of the 
relevant biological processes. The output file is visualized in 
Cytoscape V 2.8 in the form of connections along with modeling 
the network. Genes are subjected to color codes depending on 
their statistical significance and the major biological processes are 
highlighted to identify biological pathways. DAVID54 and 
PANTHER55 classification tools are also used to ascertain the 
functional classification of the Differentially Expressed genes. 
RNA isolation and qRT PCR: Total cellular RNA is extracted 
using TRIZOL reagent (Invitrogen) as per manufacturer’s 
instructions and RNA quantity as well as quality is determined 
using Nanodrop spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). The reverse transcription is performed with 
revertaid first strand cDNA synthesis kit (Thermo Scientific). 
Primer sequences used in the assay have been provided in the 
supplementary section. Four genes are chosen for validation of the 
microarray data: STAT1, BAX, BCL2L12 and IL-6. 
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characterisation of RfSH and RfS@AuNPs. It also contains the 
Figures S1—S14 and Videos S1—S4. “This material is available 
free of charge via the Internet at http://pubs.acs.org.”  
AUTHOR INFORMATION 
Corresponding Author 
*samita.basu@saha.ac.in  
*chandrima.das@saha.ac.in 
Present Addresses 
KB: Division of Biology and Biological Engineering, California 
Institute of Technology, Pasadena, CA 91125 
Author Contributions 
$These authors contributed equally.  
ACKNOWLEDGMENT  
We sincerely thank S. Haldar, R. Modok, Y. Sikdar, C. Sengupta, 
P. Mitra, S. Das Chakraborty and M. Bhattacharyya for their 
constant support and help. We acknowledge financial support 
from UGC (A. S.; F2-32/1998 (SA-1), DBT- Government of 
India, Ramalingaswami fellowship and BARD project: DAE at 
Saha Institute of Nuclear Physics.. 
REFERENCES 
 
 (1) Ndukaife, J. C.; Kildishev, A. V.; Nnanna, A. 
G. A.; Shalaev, V. M.; Wereley, S. T.; Boltasseva, A. Long-range 
and rapid transport of individual nano-objects by a hybrid 
electrothermoplasmonic nanotweezer. Nature nanotechnology 
2016, 11, 53. 
 (2) Zhao, H.; Sen, S.; Udayabhaskararao, T.; 
Sawczyk, M.; Kucanda, K.; Manna, D.; Kundu, P. K.; Lee, J.-W.; 
Král, P.; Klajn, R. Reversible trapping and reaction acceleration 
within dynamically self-assembling nanoflasks. Nature 
nanotechnology 2016, 11, 82. 
 (3) Chen, G.; Roy, I.; Yang, C.; Prasad, P. N. 
Nanochemistry and nanomedicine for nanoparticle-based 
diagnostics and therapy. Chemical reviews 2016, 116, 2826-2885. 
 (4) Bishop, K. J. Hierarchical Self‐Assembly for 
Nanomedicine. Angewandte Chemie International Edition 2016, 
55, 1598-1600. 
 (5) Abadeer, N. S.; Murphy, C. J. Recent progress 
in cancer thermal therapy using gold nanoparticles. The Journal of 
Physical Chemistry C 2016, 120, 4691-4716. 
 (6) Li, Z.; Huang, H.; Tang, S.; Li, Y.; Yu, X.-F.; 
Wang, H.; Li, P.; Sun, Z.; Zhang, H.; Liu, C. Small gold nanorods 
laden macrophages for enhanced tumor coverage in photothermal 
therapy. Biomaterials 2016, 74, 144-154. 
 (7) Aioub, M.; El-Sayed, M. A. A real-time 
surface enhanced raman spectroscopy study of plasmonic 
photothermal cell death using targeted gold nanoparticles. Journal 
of the American Chemical Society 2016, 138, 1258-1264. 
 (8) Baek, S.; Singh, R. K.; Kim, T.-H.; Seo, J.-w.; 
Shin, U. S.; Chrzanowski, W.; Kim, H.-W. Triple Hit with Drug 
Carriers: pH-and Temperature-Responsive Theranostics for 
Multimodal Chemo-and Photothermal Therapy and Diagnostic 
Applications. ACS applied materials & interfaces 2016, 8, 8967-
8979. 
 (9) Espinosa, A.; Di Corato, R.; Kolosnjaj-Tabi, 
J.; Flaud, P.; Pellegrino, T.; Wilhelm, C. Duality of iron oxide 
nanoparticles in cancer therapy: amplification of heating 
efficiency by magnetic hyperthermia and photothermal bimodal 
treatment. ACS nano 2016, 10, 2436-2446. 
 (10) Sykes, E. A.; Dai, Q.; Sarsons, C. D.; Chen, 
J.; Rocheleau, J. V.; Hwang, D. M.; Zheng, G.; Cramb, D. T.; 
Rinker, K. D.; Chan, W. C. Tailoring nanoparticle designs to 
target cancer based on tumor pathophysiology. Proceedings of the 
National Academy of Sciences 2016, 113, E1142-E1151. 
 (11) Bera, K.; Baksi, S.; Nag, M.; Bera, S. C.; 
Mukhopadhyay, D.; Basak, S. A multicolor fluorescent peptide–
nanoparticle scaffold: real time uptake and distribution in 
neuronal cells. New Journal of Chemistry 2014, 38, 2739-2743. 
 (12) Brandenberger, C.; Mühlfeld, C.; Ali, Z.; 
Lenz, A. G.; Schmid, O.; Parak, W. J.; Gehr, P.; 
Rothen‐Rutishauser, B. Quantitative Evaluation of Cellular 
Uptake and Trafficking of Plain and Polyethylene Glycol‐Coated 
Gold Nanoparticles. Small 2010, 6, 1669-1678. 
 (13) Wang, L.; Liu, Y.; Li, W.; Jiang, X.; Ji, Y.; 
Wu, X.; Xu, L.; Qiu, Y.; Zhao, K.; Wei, T. Selective targeting of 
gold nanorods at the mitochondria of cancer cells: implications for 
cancer therapy. Nano letters 2010, 11, 772-780. 
 (14) Tan, S. L.; Webster, R. D. Electrochemically 
induced chemically reversible proton-coupled electron transfer 
reactions of riboflavin (vitamin B2). Journal of the American 
Chemical Society 2012, 134, 5954-5964. 
 (15) Mantovani, S. M.; Moore, B. S. Flavin-linked 
oxidase catalyzes pyrrolizine formation of dichloropyrrole-
containing polyketide extender unit in chlorizidine A. Journal of 
the American Chemical Society 2013, 135, 18032-18035. 
 (16) Nandwana, V.; Samuel, I.; Cooke, G.; 
Rotello, V. M. Aromatic stacking interactions in flavin model 
systems. Accounts of chemical research 2012, 46, 1000-1009. 
 (17) Legrand, Y.-M.; Gray, M.; Cooke, G.; 
Rotello, V. M. Model systems for flavoenzyme activity: 
relationships between cofactor structure, binding and redox 
properties. Journal of the American Chemical Society 2003, 125, 
15789-15795. 
 (18) Sumathi, C.; Muthukumaran, P.; 
Radhakrishnan, S.; Ravi, G.; Wilson, J. Riboflavin detection by α-
Fe 2 O 3/MWCNT/AuNPs-based composite and a study of the 
interaction of riboflavin with DNA. RSC Advances 2015, 5, 
17888-17896. 
 (19) Shigemizu, D.; Hu, Z.; Hung, J.-H.; Huang, 
C.-L.; Wang, Y.; DeLisi, C. Using functional signatures to 
identify repositioned drugs for breast, myelogenous leukemia and 
prostate cancer. PLoS Comput Biol 2012, 8, e1002347. 
 (20) Thomas, T. P.; Choi, S. K.; Li, M.-H.; 
Kotlyar, A.; Baker, J. R. Design of riboflavin-presenting PAMAM 
dendrimers as a new nanoplatform for cancer-targeted delivery. 
Bioorganic & medicinal chemistry letters 2010, 20, 5191-5194. 
 (21) Sankaran, N.; Nishizawa, S.; Seino, T.; 
Yoshimoto, K.; Teramae, N. Abasic‐Site‐Containing 
Oligodeoxynucleotides as Aptamers for Riboflavin. Angewandte 
Chemie International Edition 2006, 45, 1563-1568. 
 (22) Beztsinna, N.; Solé, M.; Taib, N.; Bestel, I. 
Bioengineered riboflavin in nanotechnology. Biomaterials 2016, 
80, 121-133. 
 (23) Long, Y. F.; Liao, Q. G.; Huang, C. Z.; Ling, 
J.; Li, Y. F. Conformational Change Detection of DNA with the 
Fluorogenic Reagent of o-Phthalaldehyde-β-Mercaptoethanol. 
The Journal of Physical Chemistry B 2008, 112, 1783-1788. 
 (24) Nakabayashi, Y.; Inada, H.; Minoura, Y.; 
Iwamoto, N.; Yamauchi, O. Effects of flexible bridging ligands on 
DNA-binding of dinuclear ruthenium (II)-2, 2′-bipyridine 
complexes. Inorganica Chimica Acta 2009, 362, 869-877. 
Page 8 of 10
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  (25) Pokorny, R.; Klar, T.; Hennecke, U.; Carell, 
T.; Batschauer, A.; Essen, L.-O. Recognition and repair of UV 
lesions in loop structures of duplex DNA by DASH-type 
cryptochrome. Proceedings of the National Academy of Sciences 
2008, 105, 21023-21027. 
 (26) Poole, B.; Ohkuma, S. Effect of weak bases 
on the intralysosomal pH in mouse peritoneal macrophages. The 
Journal of cell biology 1981, 90, 665-669. 
 (27) Ly, D.; Kan, Y.; Armitage, B.; Schuster, G. B. 
Cleavage of DNA by irradiation of substituted anthraquinones: 
intercalation promotes electron transfer and efficient reaction at 
GG steps. Journal of the American Chemical Society 1996, 118, 
8747-8748. 
 (28) Leistra, A.; Witte, A.; Choi, S. K.; Sinniah, K. 
An Atomic Force Microscopy Study of Riboflavin Receptor 
Targeting Nanoparticles. Biophysical Journal 2013, 104, 556a-
557a. 
 (29) Yazdanpanah, B.; Wiegmann, K.; Tchikov, 
V.; Krut, O.; Pongratz, C.; Schramm, M.; Kleinridders, A.; 
Wunderlich, T.; Kashkar, H.; Utermöhlen, O. Riboflavin kinase 
couples TNF receptor 1 to NADPH oxidase. Nature 2009, 460, 
1159-1163. 
 (30) Wollensak, G.; Spoerl, E.; Reber, F.; Seiler, 
T. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. 
Eye 2004, 18, 718-722. 
 (31) de Souza Queiroz, K. C.; Zambuzzi, W. F.; de 
Souza, A. C. S.; da Silva, R. A.; Machado, D.; Justo, G. Z.; 
Carvalho, H. F.; Peppelenbosch, M. P.; Ferreira, C. V. A possible 
anti-proliferative and anti-metastatic effect of irradiated riboflavin 
in solid tumours. Cancer Letters 2007, 258, 126-134. 
 (32) Winey, M.; Yarar, D.; Giddings, T. H.; 
Mastronarde, D. N. Nuclear pore complex number and 
distribution throughout theSaccharomyces cerevisiae cell cycle by 
three-dimensional reconstruction from electron micrographs of 
nuclear envelopes. Molecular Biology of the Cell 1997, 8, 2119-
2132. 
 (33) Selvi, B. R.; Jagadeesan, D.; Suma, B.; 
Nagashankar, G.; Arif, M.; Balasubramanyam, K.; 
Eswaramoorthy, M.; Kundu, T. K. Intrinsically fluorescent carbon 
nanospheres as a nuclear targeting vector: delivery of membrane-
impermeable molecule to modulate gene expression in vivo. Nano 
letters 2008, 8, 3182-3188. 
 (34) Mills, J. C.; Stone, N. L.; Erhardt, J.; Pittman, 
R. N. Apoptotic membrane blebbing is regulated by myosin light 
chain phosphorylation. The Journal of cell biology 1998, 140, 
627-636. 
 (35) Coleman, M. L.; Sahai, E. A.; Yeo, M.; 
Bosch, M.; Dewar, A.; Olson, M. F. Membrane blebbing during 
apoptosis results from caspase-mediated activation of ROCK I. 
Nature cell biology 2001, 3, 339-345. 
 (36) Cook, P. J.; Ju, B. G.; Telese, F.; Wang, X.; 
Glass, C. K.; Rosenfeld, M. G. Tyrosine dephosphorylation of 
H2AX modulates apoptosis and survival decisions. Nature 2009, 
458, 591-596. 
 (37) Gregory, C. D. Cell biology: the disassembly 
of death. Nature 2014, 507, 312-313. 
 (38) di Fagagna, F. d. A.; Reaper, P. M.; Clay-
Farrace, L.; Fiegler, H.; Carr, P.; von Zglinicki, T.; Saretzki, G.; 
Carter, N. P.; Jackson, S. P. A DNA damage checkpoint response 
in telomere-initiated senescence. Nature 2003, 426, 194-198. 
 (39) Bartkova, J.; Hořejší, Z.; Koed, K.; Krämer, 
A.; Tort, F.; Zieger, K.; Guldberg, P.; Sehested, M.; Nesland, J. 
M.; Lukas, C. DNA damage response as a candidate anti-cancer 
barrier in early human tumorigenesis. Nature 2005, 434, 864-870. 
 (40) Löbrich, M.; Rief, N.; Kühne, M.; Heckmann, 
M.; Fleckenstein, J.; Rübe, C.; Uder, M. In vivo formation and 
repair of DNA double-strand breaks after computed tomography 
examinations. Proceedings of the National Academy of Sciences 
of the United States of America 2005, 102, 8984-8989. 
 (41) Petersen, S.; Casellas, R.; Reina-San-Martin, 
B.; Chen, H. T.; Difilippantonio, M. J.; Wilson, P. C.; Hanitsch, 
L.; Celeste, A.; Muramatsu, M.; Pilch, D. R. AID is required to 
initiate Nbs1/γ-H2AX focus formation and mutations at sites of 
class switching. Nature 2001, 414, 660-665. 
 (42) Varmark, H.; Sparks, C. A.; Nordberg, J. J.; 
Koppetsch, B. S.; Theurkauf, W. E. DNA damage-induced cell 
death is enhanced by progression through mitosis. Cell Cycle 
2009, 8, 2952-2964. 
 (43) Elledge, S. J. Cell cycle checkpoints: 
preventing an identity crisis. Science 1996, 274, 1664. 
 (44) Park, K.-J.; Lee, C.-H.; Kim, A.; Jeong, K. J.; 
Kim, C.-H.; Kim, Y.-S. Death receptors 4 and 5 activate Nox1 
NADPH oxidase through riboflavin kinase to induce reactive 
oxygen species-mediated apoptotic cell death. Journal of 
Biological Chemistry 2012, 287, 3313-3325. 
 (45) Camporeale, G.; Zempleni, J. Oxidative 
folding of interleukin-2 is impaired in flavin-deficient Jurkat cells, 
causing intracellular accumulation of interleukin-2 and increased 
expression of stress response genes. The Journal of nutrition 
2003, 133, 668-672. 
 (46) Pawlowski, J.; Kraft, A. S. Bax-induced 
apoptotic cell death. Proceedings of the National Academy of 
Sciences 2000, 97, 529-531. 
 (47) Oh, Y. S.; Lee, Y. J.; Park, E. Y.; Jun, H. S. 
Interleukin‐6 treatment induces beta‐cell apoptosis via 
STAT‐3‐mediated nitric oxide production. Diabetes/metabolism 
research and reviews 2011, 27, 813-819. 
 (48) Zhang, J.; Zhang, Y.; Dutta, D. J.; Argaw, A. 
T.; Bonnamain, V.; Seto, J.; Braun, D. A.; Zameer, A.; Hayot, F.; 
Lòpez, C. B.; Raine, C. S.; John, G. R. Proapoptotic and 
Antiapoptotic Actions of Stat1 versus Stat3 Underlie 
Neuroprotective and Immunoregulatory Functions of IL-11. The 
Journal of Immunology 2011, 187, 1129-1141. 
 (49) Chou, C.-H.; Chou, A.-K.; Lin, C.-C.; Chen, 
W.-J.; Wei, C.-C.; Yang, M.-C.; Hsu, C.-M.; Lung, F.-W.; Loh, 
J.-K.; Howng, S.-L. GSK3β regulates Bcl2L12 and Bcl2L12A 
anti-apoptosis signaling in glioblastoma and is inhibited by LiCl. 
Cell Cycle 2012, 11, 532-542. 
 (50) Sau, A.; Bera, K.; Mondal, P.; Satpati, B.; 
Basu, S. Distance-Dependent Electron Transfer in Chemically 
Engineered Carbon Dots. The Journal of Physical Chemistry C 
2016, 120, 26630-26636. 
 (51) Lopez-Acevedo, O.; Akola, J.; Whetten, R. 
L.; Grönbeck, H.; Häkkinen, H. Structure and bonding in the 
ubiquitous icosahedral metallic gold cluster Au144 (SR) 60. The 
Journal of Physical Chemistry C 2009, 113, 5035-5038. 
 (52) Pal, U.; Pramanik, S. K.; Bhattacharya, B.; 
Banerji, B.; Maiti, N. C. Binding interaction of a gamma. 
SpringerPlus 2016, 5, 1-17. 
 (53) Bowers, K. J.; Chow, E.; Xu, H.; Dror, R. O.; 
Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; 
Moraes, M. A.; Sacerdoti, F. D. In Tilte2006; ACM. 
 (54) Huang, D. W.; Sherman, B. T.; Lempicki, R. 
A. Bioinformatics enrichment tools: paths toward the 
comprehensive functional analysis of large gene lists. Nucleic 
acids research 2008, 37, 1-13. 
 (55) Thomas, P. D.; Kejariwal, A.; Guo, N.; Mi, 
H.; Campbell, M. J.; Muruganujan, A.; Lazareva-Ulitsky, B. 
Applications for protein sequence–function evolution data: 
mRNA/protein expression analysis and coding SNP scoring tools. 
Nucleic acids research 2006, 34, W645-W650. 
   
Page 9 of 10
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Content: 
 
 
Page 10 of 10
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
